JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.3B |
| 2 |
McDonald's
MCD
|
+$2.2B |
| 3 |
Microsoft
MSFT
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.94B |
| 5 |
Goldman Sachs
GS
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.77B |
| 2 |
Broadcom
AVGO
|
+$1.88B |
| 3 |
TSMC
TSM
|
+$1.18B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.14B |
| 5 |
Danaher
DHR
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Healthcare | 9.24% |
| 3 | Consumer Discretionary | 9.21% |
| 4 | Financials | 9.1% |
| 5 | Industrials | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4376
Neumora Therapeutics
NMRA
$301M
| $851K | ﹤0.01% |
64,421
+1,629
| +3% | +$19K |
|
|
DAWN
4377
DELISTED
Day One Biopharmaceuticals
DAWN
| $849K | ﹤0.01% |
60,983
+530
| +0.9% | +$7.56K |
|
4378
Caribou Biosciences
CRBU
$169M
| $849K | ﹤0.01% |
433,359
-30,668
| -7% | -$62.8K |
|
4379
Malibu Boats
MBUU
$576M
| $849K | ﹤0.01% |
21,885
-278,772
| -93% | -$10M |
|
4380
PIMCO RAFI Multi-Factor International Equity ETF
MFDX
$472M
| $848K | ﹤0.01% |
26,095
-9,875
| -27% | -$307K |
|
4381
CALL
Clorox
CLX
$12.8B
| $847K | ﹤0.01% |
5,200
+1,200
| +30% | +$178K |
|
4382
PUT
DexCom
DXCM
$33.9B
| $845K | ﹤0.01% |
12,600
-23,400
| -65% | -$1.92M |
|
4383
JPMorgan Diversified Return US Small Cap Equity ETF
JPSE
$611M
| $844K | ﹤0.01% |
17,580
+1,602
| +10% | +$73.9K |
|
4384
Bumble
BMBL
$358M
| $841K | ﹤0.01% |
131,854
+2,760
| +2% | +$20.8K |
|
4385
Freedom Holding
FRHC
$9.34B
| $840K | ﹤0.01% |
8,863
+124
| +1% | +$10.8K |
|
4386
CALL
KeyCorp
KEY
$25B
| $838K | ﹤0.01% |
50,000
-50,000
| -50% | -$793K |
|
4387
Precigen
PGEN
$2.18B
| $837K | ﹤0.01% |
884,275
-194,514
| -18% | -$245K |
|
4388
Janux Therapeutics
JANX
$986M
| $836K | ﹤0.01% |
18,392
-821
| -4% | -$35.7K |
|
4389
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.29B
| $833K | ﹤0.01% |
10,101
-3,196
| -24% | -$257K |
|
|
MSB
4390
Mesabi Trust
MSB
$301M
| $829K | ﹤0.01% |
36,611
-6,355
| -15% | -$116K |
|
|
CTLP
4391
DELISTED
Cantaloupe
CTLP
| $824K | ﹤0.01% |
111,394
+86,109
| +341% | +$592K |
|
4392
SGHC Ltd
SGHC
$6.76B
| $824K | ﹤0.01% |
226,906
+116,740
| +106% | +$402K |
|
4393
iShares MSCI Turkey ETF
TUR
$222M
| $824K | ﹤0.01% |
22,639
-7,763
| -26% | -$305K |
|
4394
Tootsie Roll Industries
TR
$3.08B
| $823K | ﹤0.01% |
28,185
+20,737
| +278% | +$590K |
|
|
WDI
4395
Western Asset Diversified Income Fund
WDI
$687M
| $823K | ﹤0.01% |
52,460
+12,211
| +30% | +$185K |
|
4396
State Street SPDR S&P Telecom ETF
XTL
$559M
| $822K | ﹤0.01% |
8,172
+44
| +0.5% | +$3.93K |
|
|
RERE
4397
ATRenew
RERE
$1.01B
| $818K | ﹤0.01% |
294,187
-43,586
| -13% | -$106K |
|
4398
CALL
NIO
NIO
$11.3B
| $818K | ﹤0.01% |
122,400
+102,600
| +518% | +$472K |
|
4399
Lemonade
LMND
$4.07B
| $816K | ﹤0.01% |
49,465
-7,696
| -13% | -$141K |
|
4400
PUT
Lucid Motors
LCID
$2.45B
| $812K | ﹤0.01% |
+23,010
| New | +$802K |
|
Similar funds
JP Morgan Chase's Q3 2024 Portfolio in Review
As of Q3 2024, JP Morgan Chase held 7,854 positions worth $1.32T, up 7.9% from $1.22T the previous quarter. Its ten largest holdings account for 23% of the portfolio.
JP Morgan Chase's Q3 2024 filing shows 533 new, 3,476 increased, 2,341 reduced and 444 closed positions. Its largest new stake was Smurfit Westrock: 4,472,396 shares worth $221M. The largest sale was Advanced Micro Devices, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- JP Morgan Chase's largest Q3 2024 buy was Smurfit Westrock: 4,472,396 shares worth $221M.
- JP Morgan Chase added most to iShares Broad USD High Yield Corporate Bond ETF in Q3 2024, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q3 2024 reduction was Advanced Micro Devices, cutting an estimated $2.77B.
- JP Morgan Chase fully exited WestRock Company in Q3 2024, selling an estimated $320M.
- JP Morgan Chase's ten largest holdings make up 23% of its $1.32T portfolio in Q3 2024.
- JP Morgan Chase opened 533 new positions and closed 444 in Q3 2024.
- JP Morgan Chase's portfolio value rose 7.9% quarter-over-quarter to $1.32T.
Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.